Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling

Carcinogenesis. 2010 Mar;31(3):481-8. doi: 10.1093/carcin/bgp292. Epub 2009 Dec 7.

Abstract

As a critical factor in the induction of angiogenesis, vascular endothelial growth factor (VEGF) has become an attractive target for anti-angiogenesis treatment. However, the side effects associated with most anti-VEGF agents limit their chronic use. Identification of naturally occurring VEGF inhibitors derived from diet is a potential alternative approach, with the advantage of known safety. To isolate natural inhibitors of VEGF, we established an in vitro tyrosine kinase assay to screen for diet-based agents that suppress VEGFR2 kinase activity. We found that a water-based extract from cinnamon (cinnamon extract, CE), one of the oldest and most popular spices, was a potent inhibitor of VEGFR2 kinase activity, directly inhibiting kinase activity of purified VEGFR2 as well as mitogen-activated protein kinase- and Stat3-mediated signaling pathway in endothelial cells. As a result, CE inhibited VEGF-induced endothelial cell proliferation, migration and tube formation in vitro, sprout formation from aortic ring ex vivo and tumor-induced blood vessel formation in vivo. Depletion of polyphenol from CE with polyvinylpyrrolidone abolished its anti-angiogenesis activity. While cinnamaldehyde, a component responsible for CE aroma, had little effect on VEGFR2 kinase activity, high-performance liquid chromatography-purified components of CE, procyanidin type A trimer (molecular weight, 864) and a tetramer (molecular weight, 1152) were found to inhibit kinase activity of purified VEGFR2 and VEGFR2 signaling, implicating procyanidin oligomers as active components in CE that inhibit angiogenesis. Our data revealed a novel activity in cinnamon and identified a natural VEGF inhibitor that could potentially be useful in cancer prevention and/or treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / isolation & purification
  • Angiogenesis Inhibitors / pharmacology*
  • Animals
  • Aorta, Thoracic / drug effects
  • Biflavonoids / isolation & purification
  • Biflavonoids / pharmacology
  • Breast Neoplasms / pathology
  • Catechin / isolation & purification
  • Catechin / pharmacology
  • Cattle
  • Cell Division / drug effects
  • Cell Line, Tumor / drug effects
  • Cell Line, Tumor / enzymology
  • Cell Line, Tumor / transplantation
  • Cell Movement / drug effects
  • Cells, Cultured / cytology
  • Cells, Cultured / drug effects
  • Cells, Cultured / enzymology
  • Chick Embryo
  • Cinnamomum zeylanicum / chemistry*
  • Collagen
  • Drug Combinations
  • Endothelial Cells / cytology
  • Endothelial Cells / drug effects*
  • Endothelial Cells / enzymology
  • Female
  • Humans
  • Laminin
  • Male
  • Mice
  • Mice, SCID
  • Morphogenesis / drug effects
  • Neovascularization, Physiologic / drug effects
  • Phosphorylation / drug effects
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology*
  • Proanthocyanidins / isolation & purification
  • Proanthocyanidins / pharmacology
  • Protein Processing, Post-Translational / drug effects
  • Proteoglycans
  • Signal Transduction / drug effects
  • Vascular Endothelial Growth Factor Receptor-2 / antagonists & inhibitors*
  • Xenograft Model Antitumor Assays

Substances

  • Angiogenesis Inhibitors
  • Biflavonoids
  • Drug Combinations
  • Laminin
  • Plant Extracts
  • Proanthocyanidins
  • Proteoglycans
  • matrigel
  • procyanidin
  • Catechin
  • Collagen
  • Vascular Endothelial Growth Factor Receptor-2